Adults living with obesity or overweight who do not have type 2 diabetes may qualify for a research study evaluating an investigational once-weekly injectable medication for weight management.
Overweight Study
Age Range:
18
Gender:
Male and Female
Location:
Rochester, New York
About the Study
The purpose of this study is to better understand how well the investigational treatment works in reducing body weight, improving weight-related health measures, and evaluating its safety and tolerability. Researchers will also study how the investigational medication may affect blood sugar levels, cholesterol, blood pressure, body composition, and quality of life.
Qualifications
Qualifications
You may be able to join if you:
-Are at least 18 years of age
-Have obesity with a body mass index (BMI) of 30 or greater
OR have overweight with a BMI of 27 or greater and at least one weight-related medical condition
-Have a history of at least one unsuccessful dietary effort to reduce body weight
-Do not have type 2 diabetes
FEATURED STUDIES
Researchers are studying an investigational medication to see how effective it may be as a potential weight reduction treatment. If […]
Adults 18 years and older may qualify for a study evaluating investigational treatment options for diabetic peripheral neuropathic pain (DPNP), […]
Adults 18 years and older may qualify for a study evaluating an investigational oral study medication for elevated lipoprotein(a) [Lp(a)], […]
Adults living with obesity or overweight who do not have type 2 diabetes may qualify for a research study evaluating […]
Adults living with obesity or overweight who do not have type 2 diabetes may qualify for a research study evaluating […]
Adults who are overweight or obese and currently using semaglutide (Ozempic®/Wegovy®) or tirzepatide (Mounjaro®/Zepbound®) may qualify for a research study […]